良いプロトコルは、『何が変われば成功か』を先に分けている
The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial
Other ｜ 2021 ｜ 呼吸・嚥下 / 脳卒中回復・評価・介入
脳卒中／摂食嚥下／呼吸筋訓練／研究プロトコル
30秒でつかむ
- 何を調べた？
- 亜急性期脳卒中嚥下障害への吸気・呼気筋訓練をshamと比較するRCT計画書。
- 何が分かった？
- 呼吸筋力、VFSS嚥下、咳嗽、呼吸器合併症、栄養を別アウトカムとして前向きに測る。
- 何を言ってはいけない？
- 2021年論文から嚥下・誤嚥・肺炎への有効性結果は言えない。
重要ポイント
- プロトコルは問い、比較、測定、解析計画を評価する資料。
- 呼吸筋力、嚥下安全性、食事、肺炎を別階層に置く。
- 後続資料は計画変更と資料種別を明示する。
文書を読み解く2〜4分
研究の要点
A rigorously planned sham-controlled trial with blinded assessment and multiple outcome levels; the 2021 publication is methods-only.
研究デザイン
Protocol for a 1:1 randomized, sham-controlled, double-blind trial with six-month follow-up.
対象
Planned n=50; first ischemic stroke, >3 weeks post-onset, VFSS/FEES-confirmed oropharyngeal dysphagia, MMSE >24.
介入
Orygen Dual Valve inspiratory and expiratory training at 10RM, weekly adjustment up to 10 cmH2O, 5 sets x 10 repetitions, 3 times/day, 7 days/week for 8 weeks; sham comparator.
アウトカム
Planned primary outcomes included PImax, PEmax and VFSS dysphagia severity; cough flow, tongue pressure, respiratory complications, nutrition/body composition and six-month follow-up were also planned.
限界
The 2021 article contains no efficacy or safety results.
Protocol, current registry and 2026 thesis differ in sample counts, dose wording and blinding descriptors.
Later thesis results are not a peer-reviewed journal result article.
資金・利益相反
FEDER/Instituto de Salud Carlos III PI16/01081 and Generalitat de Catalunya support; authors declared no competing interests. The device was developed and patented at the authors' institution.
原典から臨床へ
① 原典で提示されていること原典
The 2021 article directly verifies eligibility, allocation, sham, dose, outcomes, analysis, funding and COI plans; it contains no group efficacy or harm results.
①′ 原典での位置づけ原典・著者の考察
The authors expected respiratory training to influence strength, cough and swallowing and proposed a trial to test efficacy and safety.
② 療活ではどう考えるか療活編集部の整理・ここからは原典そのものではありません
Use the protocol to audit later reporting. Keep the 2026 thesis's respiratory-strength signal and null PAS/BRS/FOIS/complication differences separate from the 2021 paper.
③ 臨床で観察するとしたら療活編集部
Monitor training load and adherence, fatigue and adverse events, PImax/PEmax, PCF, VFSS/FEES, FOIS, intake, nutrition, pneumonia and participation.
④ まだ言えないこと
From the 2021 paper: all efficacy and safety results; from the research program: peer-reviewed result publication, durable swallowing and participation benefit.
この研究と臨床の距離
Protocol to implemented results, peer-reviewed result publication, replication, patient selection and long-term meal participation.
逆の視点から読んでみる
A detailed protocol can change during COVID-era recruitment and implementation; sham and usual care can improve outcomes, so within-group gains are not added efficacy.
この文献を読んだあと、何を見る？
Compare preregistered outcomes, actual denominators, protocol changes, missing data and between-group effects in every later result source.
考えてみましょう
If respiratory strength improves but PAS and FOIS do not, what enablement link is missing?
How do protocol deviations alter interpretation?
答えを急ぐ必要はありません。次の臨床で、少し観察してみてください。
同じ領域の文献
原典・書誌情報
Guillen-Sola A, Messaggi-Sartor M, Ramírez-Fuentes C, Marco E, Duarte E. The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial. Trials. 2021;22:416.
原典照合：大塚 久（原典照合＝AI・Trials Version of Record / PMC; protocol only・2026-08-29）／最終確認日：2026-08-29
確認状況：書誌確認・抄録確認・全文入手可・全文照合・主要数値確認・臨床Bridge確認